VANCOUVER, June 26 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today announced the results of the Annual Shareholders Meeting held on June 26, 2008 in Shenzhen, China.
There were 48,663,865 shares equaling 69.81% of the outstanding shares represented at this meeting. The shareholders re-elected the following eight persons to serve as members of the Board of Directors for the Company: Mr. Yanlin Han, Mr. Zhanguo Weng, Ms. Xuemei Liu, Dr. Alexander Wick, Ph.D., Dr. Yiu Kwong Sun, M.D., Mr. Peter Mak, Dr. Heinz Frey and Mr. Jin Li.
CONTACT: Dragon Pharmaceutical Inc., Maggie Deng, COO, Telephone: (604)-669-8817 or North America Toll Free: 1-877-388-3784, Email: firstname.lastname@example.org, Website: http://www.dragonpharma.com
|SOURCE Dragon Pharmaceutical Inc.|
Copyright©2008 PR Newswire.
All rights reserved